AtherosclerosisPeter Libby, Eldrin F. Lewis, Julie E. Buring et al.|Nature Reviews Disease Primers|2019Cited by 3k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary SyndromeMarc A. Pfeffer, Jean‐Claude Tardif, Brian Claggett et al.|New England Journal of Medicine|2015Cited by 2.3k
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart AssociationChiadi E. Ndumele, Mitchell S.V. Elkind, Janani Rangaswami et al.|Circulation|2023Cited by 1.7k
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart AssociationChiadi E. Ndumele, Janani Rangaswami, Ian J. Neeland et al.|Circulation|2023Cited by 1.1k
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) TrialMarc A. Pfeffer, Bertram Pitt, Brian Claggett et al.|Circulation|2014Cited by 1k